Repligen
RGEN
311 hedge funds and large institutions have $4.51B invested in Repligen in 2020 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 101 increasing their positions, 118 reducing their positions, and 42 closing their positions.
267% more funds holding in top 10
Funds holding in top 10: 3 → 11 (+8)
17% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 42
12% more capital invested
Capital invested by funds: $4.04B → $4.51B (+$472M)
6.22% more ownership
Funds ownership: 83.91% → 90.13% (+6.2%)
2% more funds holding
Funds holding: 306 → 311 (+5)
14% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 118
16% less call options, than puts
Call options by funds: $13.6M | Put options by funds: $16.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$135M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$78.9M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$54.5M |
| 4 |
Select Equity Group
New York
|
+$47M |
| 5 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$45.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$43.3M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29.3M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$21.2M |
| 4 |
FAM
Fred Alger Management
New York
|
-$19M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$18.6M |
RGEN Hedge Fund Activity: Q1 2020 in Review
311 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q1 2020, worth a combined $4.51B — up 12% from $4.04B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new RGEN positions and 42 closed out — a net gain of 7 holders — while 101 added to existing stakes and 118 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $135M. The largest seller was Federated Hermes, cutting an estimated $43.3M.
- 311 institutional investors held Repligen (RGEN) as of Q1 2020, up from 306 in Q4 2019.
- Funds reported $4.51B of Repligen stock for Q1 2020, up 12% quarter-over-quarter.
- 49 funds opened new Repligen positions in Q1 2020 and 42 closed out, a net change of +7 holders.
- The largest Repligen buyer in Q1 2020 was T. Rowe Price Associates, an estimated $135M added.
- The largest Repligen seller in Q1 2020 was Federated Hermes, an estimated $43.3M sold.
Based on aggregated 13F filings for Q1 2020.